ISS Backs Kenvue (KVUE) Deal, Investors Debate Tylenol and Litigation Risks
Kenvue Inc. (NYSE:KVUE) is looking to potentially reshape the consumer health landscape, as it received institutional support for its proposed merger with Kimberly-Clark.
Kenvue Inc. (KVUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kapitalo Investimentos Jo„O Carlos Pinho And Carlos Woelz | 2,000,000 | $34,500,000 | +25% | 6.6% |
| 2. | Levin Capital Strategies John A. Levin | 41,757 | $720,308 | +243% | 0.06% |
| 3. | 15,000 | $258,750 | 0.02% | ||
| 4. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.37 | 3,200,000 | $55,593,600.00 | 27,307,632 | 2025-12-12 | Filing | |
| $17.43 | 3,177,694 | $55,392,926.27 | 24,107,632 | 2025-12-11 | Filing | |
| $22.96 | 5,598 | $128,523.92 | 25,598 | 2023-08-30 | Filing | |
| $26.26 | 20,000 | $525,232.00 | 20,000 | 2023-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.03 | 17,100 | $393,813.00 | 56,316 | 2025-03-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 234,951,484 | $4,052,913,099 | 0.06% | |
| 2. | 68,486,378 | $1,181,390,023 | 0.38% | |
| 3. | 41,751,972 | $720,221,518 | 0.12% | |
| 4. | 2,334,186 | $490,972,991 | 1.58% | |
| 5. | 5,217,558 | $90,002,876 | 0.05% |
News See All
10 Undervalued Wide Moat Stocks to Buy Right Now
As U.S. markets go further into 2026, they are witnessing a shift in the macro backdrop that is reshaping expectations across asset classes. Following a sluggish 2025, U.S.
Here’s What Impacted Kenvue’s (KVUE) in Q3
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Kenvue Inc. (KVUE): A Bull Case Theory
We came across a bullish thesis on Kenvue Inc. on The Value Road’s Substack.
9 Stocks on Jim Cramer’s Radar Recently
“So on any given day, there's so many stocks that can make us money, yet they are devoid, they're forlorn of promotion, of pizazz.
SCCM Value Equity Fund Sold Kenvue (KVUE) Due to Less Compelling Valuation
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Value Equity Strategy” third-quarter investor letter.
Kenvue (KVUE) Jumps 17% on Strong Earnings, Kimberly-Clark $48.7-Billion Merger
Kenvue grew its share prices by 17.47 percent week-on-week, as investors loaded portfolios following twin news that it achieved a strong earnings performance in the past quarter of the year, alongside...
Kenvue (KVUE) Announces Financial Results for Q3 2025
Kenvue Inc. (NYSE:KVUE) is one of the Best Low Priced Stocks to Buy According to Analysts.
12 Best Low Priced Stocks to Buy According to Analysts
Andrew Slimmon, Senior Portfolio Manager at Morgan Stanley Investment Management, discussed broader market trends on CNBC, highlighting that the biggest worry in the current environment is that the market...
Kimberly-Clark (KVUE) Buying Kenvue Isn't A Mistake, Asserts Jim Cramer
Personal healthcare products provider Kenvue Inc. (NYSE:KVUE) has been in the news for one reason or another recently.
Hedge Fund Resource Center Billionaire Hedge Funds
